We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 11-20 of 1,508

The climate report - summer 2014 - climate change litigation

  • Jones Day
  • -
  • USA
  • -
  • August 13 2014

In its third encounter with greenhouse gas emissions in the context of the Clean Air Act ("CAA"), the United States Supreme Court, in Utility Air

The climate report - summer 2014 - risky business report outlines regional climate change risks

  • Jones Day
  • -
  • USA
  • -
  • August 13 2014

As reported in Jones Day's Fall 2013 Climate Report, Risky Business, an initiative cochaired by hedge fund billionaire Tom Steyer, former U.S

The climate report - summer 2014 - U.S. regulatory developments

  • Jones Day
  • -
  • USA
  • -
  • August 13 2014

The United States Supreme Court's recent decision in UARG v. EPA offers insight as to how future courts will evaluate the authority of the

Parallel litigation and inter partes review: don't forget about reissue

  • Jones Day
  • -
  • USA
  • -
  • August 13 2014

Inter partes review ("IPR") was introduced by the America Invents Act ("AIA") to provide a trial-like proceeding for challenging the patentability of

When is a commissioned salesperson exempt from overtime in California?

  • Jones Day
  • -
  • USA
  • -
  • August 13 2014

California and federal law establish different requirements for the so-called "commissioned employee" overtime exemption. This exemption allows many

Food, dietary supplement & cosmetics regulatory update, Issue 11

  • Jones Day
  • -
  • Canada, China, USA
  • -
  • August 8 2014

Last week, a divided federal appeals court ruled that FDA cannot be forced to ban antibiotics in food-producing healthy livestock. Thedecision comes

FDA issues draft guidance on determination of reference product exclusivity for biologics

  • Jones Day
  • -
  • USA
  • -
  • August 7 2014

On August 4, the U.S. Food & Drug Administration ("FDA") issued a draft guidance titled "Reference Product Exclusivity for Biological Products Filed

Amending claims during inter partes review: patent practitioners beware

  • Jones Day
  • -
  • USA
  • -
  • August 5 2014

Although patent owners are theoretically allowed to amend patent claims during an inter partes review ("IPR") proceeding at the U.S. Patent and

Backoff point-of-sale malware: here we go again

  • Jones Day
  • -
  • USA
  • -
  • August 1 2014

The Secret Service, the National Cybersecurity and Communications Integration Center, and others announced yesterday in a US-CERT Alert (available at

D.C. Circuit holds that CFIUS must provide due process before prohibiting a transaction

  • Jones Day
  • -
  • USA
  • -
  • July 31 2014

The U.S. Court of Appeals for the D.C. Circuit has issued a landmark opinion granting due process rights to parties whose transactions have been